Levels of vascular endothelial growth factor-A165b (VEGF-A165b) are elevated in experimental glaucoma
2008

VEGF-A165b Levels in Experimental Glaucoma

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): Ergorul Ceren, Ray Arjun, Huang Wei, Darland Diane, Luo Zhonghui K., Grosskreutz Cynthia L.

Primary Institution: Massachusetts Eye and Ear Infirmary, Harvard Medical School

Hypothesis

The levels of VEGF-A165b but not VEGF-A164 would be increased in the glaucomatous retina.

Conclusion

Five days of elevated intraocular pressure leads to an increase in VEGF-A165b levels in the glaucomatous retina, which return to baseline after 10 days.

Supporting Evidence

  • VEGF-A164 levels remained unchanged in glaucomatous retinas after five and ten days of elevated IOP.
  • VEGF-A165b levels were significantly increased in glaucomatous retinas after five days of elevated IOP.
  • VEGF-A165b levels returned to baseline after ten days of elevated IOP.

Takeaway

In a study with rats, scientists found that a protein called VEGF-A165b increases when the eye pressure is high for a short time, but goes back to normal after a longer time.

Methodology

Glaucoma was induced in rats by injecting hypertonic saline, and levels of VEGF-A164 and VEGF-A165b were analyzed using western blotting and immunohistochemistry.

Limitations

The study was conducted on a small sample size of rats, which may limit the generalizability of the findings.

Participant Demographics

Male retired breeder Brown Norway rats, weighing 300-450 g.

Statistical Information

P-Value

0.014

Statistical Significance

p=0.014

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication